BriaCell Therapeutics (BCT) News Today C$10.60 -0.42 (-3.81%) (As of 12/30/2021) Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period BriaCell Therapeutics Confronts Financial Challenges Amid Volatile Markets and Potential Shareholder DilutionOctober 31, 2024 | markets.businessinsider.comBriaCell’s Promising Breast Cancer Study ResultsOctober 22, 2024 | markets.businessinsider.comBriaCell Therapeutics Corp.: BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival DataOctober 22, 2024 | finanznachrichten.deBriaCell Therapeutics advances Phase 3 MBC clinical studyOctober 16, 2024 | msn.comBCT:CA BriaCell Therapeutics Corp.September 21, 2024 | seekingalpha.comBriaCell Therapeutics Corp. (BCTXW)September 18, 2024 | ca.finance.yahoo.comBriaCell Says FDA Authorizes Expanded Access Policy For Patients With Metastatic Breast CancerSeptember 18, 2024 | markets.businessinsider.comBriaCell Therapeutics Corp.: BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast CancerSeptember 11, 2024 | finanznachrichten.deBriaCell Therapeutics Shares Double on Positive Trial News for Breast Cancer TreatmentSeptember 11, 2024 | marketwatch.comBriaCell Reports Positive OS Data Of Its Phase 2 Clinical Study Of Bria-IMT In Breast CancerSeptember 11, 2024 | markets.businessinsider.comBriaCell Therapeutics Corp.: BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+ for Prostate CancerSeptember 10, 2024 | finanznachrichten.deBriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+(TM) for Prostate CancerSeptember 10, 2024 | stockhouse.comStocks in play: BriaCell Therapeutics Corp.September 9, 2024 | ca.finance.yahoo.comBriaCell Therapeutics Corp. (BCT.TO)February 29, 2024 | ca.finance.yahoo.comBriaCell shares rise on strong data from breast cancer treatment studyFebruary 7, 2024 | msn.comBriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder CaseFebruary 7, 2024 | markets.businessinsider.comBriaCell Shares Advance as Production of Lead Candidate BeginsFebruary 6, 2024 | marketwatch.comBriaCell Therapeutics Corp.: BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer PatientsDecember 28, 2023 | finanznachrichten.deBriaCell's Bria-IMT Regimen Shows 71% Intracranial ORR In Breast Cancer PatientsDecember 28, 2023 | markets.businessinsider.comBriaCell Therapeutics Reports Preliminary Survival Benefit Data In Bria-IMT RegimenDecember 20, 2023 | markets.businessinsider.comHere's Why We're Watching BriaCell Therapeutics' (TSE:BCT) Cash Burn SituationDecember 1, 2023 | finance.yahoo.comBriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS™ INDNovember 3, 2023 | finance.yahoo.comClosing Bell: Briacell Therapeutics Corp flat on Tuesday (BCT)October 18, 2023 | theglobeandmail.comBriaCell Partners with New York Cancer & Blood Specialists (NYCBS) for Pivotal Phase 3 Study of Bria-IMT(TM) in Advanced Breast CancerOctober 6, 2023 | stockhouse.comBriaCell Initiates Pivotal Phase 3 Study of Bria-IMT™ in Advanced Metastatic Breast CancerOctober 3, 2023 | finance.yahoo.comClosing Bell: Briacell Therapeutics Corp up on Tuesday (BCT)September 27, 2023 | theglobeandmail.comBriaCell Therapeutics (BCT) Initiated with a Buy at H.C. WainwrightSeptember 8, 2023 | markets.businessinsider.comClosing Bell: Briacell Therapeutics Corp down on Wednesday (BCT)August 17, 2023 | theglobeandmail.comBriaCell Awarded National Cancer Institute Grant to Advance its Bria-OTS™ Immunotherapy for CancerAugust 16, 2023 | finance.yahoo.comBriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDailyMay 30, 2023 | finance.yahoo.comBriaCell Therapeutics Corp.: BriaCell Enters Definitive Arrangement Agreement for the Spin Out of BriaPro Therapeutics Corp.May 25, 2023 | finanznachrichten.deClosing Bell: Briacell Therapeutics Corp down on Friday (BCT)May 6, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp down on Tuesday (BCT)April 26, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp down on Monday (BCT)April 25, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp up on Thursday (BCT)April 21, 2023 | theglobeandmail.comPositive Developments for Breast Cancer Care Attracting Big Investor AttentionApril 17, 2023 | baystreet.caClosing Bell: Briacell Therapeutics Corp up on Friday (BCT)April 15, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp up on Wednesday (BCT)April 13, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp up on Monday (BCT)April 11, 2023 | theglobeandmail.comBriaCell Announces Intention to Spin-Out Certain Pre-Clinical Assets into a Newly Created “SpinCo” Entity whereby Shareholders to Receive One New Share of “SpinCo” in Addition to Each Current Share of BriaCell Already HeldMarch 30, 2023 | finance.yahoo.comBreast Cancer Treatment Options Evolved Over the Last 12 Months, Bringing More Hope for 2023March 14, 2023 | baystreet.caBriaCell Therapeutics Corp. (TSE:BCT) most popular amongst individual investors who own 59%, insiders hold 14%February 11, 2023 | finance.yahoo.comBriaCell CEO Letter to ShareholdersJanuary 24, 2023 | finance.yahoo.comBriaCell to investigate alleged illegal trading activity by outsidersJanuary 23, 2023 | finance.yahoo.comBriaCell to Investigate Alleged Illegal Trading of Public SecuritiesJanuary 23, 2023 | finance.yahoo.comBriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT™ Combination in Advanced Metastatic Breast CancerJanuary 18, 2023 | finance.yahoo.comBriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer PatientsDecember 2, 2022 | finance.yahoo.comBCTX: SITC Poster PresentationNovember 21, 2022 | finance.yahoo.comBriaCell CEO Discusses Positive Clinical Results of its Breast Cancer Immunotherapy Treatment in an Audio Interview with SmallCapVoice.comNovember 15, 2022 | finance.yahoo.comBriaCell to Present New Clinical Data at the 2022 San Antonio Breast Cancer Symposium® December 6th and 7thSeptember 28, 2022 | finance.yahoo.com Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race… Click here to see a unique election-year trade BCT Media Mentions By Week BCT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCT News Sentiment▼-0.310.44▲Average Medical News Sentiment BCT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCT Articles This Week▼10▲BCT Articles Average Week Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Medicenna Therapeutics News Fennec Pharmaceuticals News Oncolytics Biotech News Covalon Technologies News Sernova News Theratechnologies News Microbix Biosystems News Resverlogix News Kane Biotech News Aeterna Zentaris News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:BCT) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
